OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PHAT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Phathom Pharmaceuticals (PHAT) Earnings Date & Reports

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PHAT is expected to report earnings to fall 28.32% to -56 cents per share on November 06

Phathom Pharmaceuticals PHAT Stock Earnings Reports

Q3'25

Est.

$-0.57

Q2'25

Beat

by $0.12

Q1'25

Beat

by $0.04

Q4'24

Beat

by $0.42

Q3'24

Beat

by $0.15

The last earnings report on August 07 showed earnings per share of -79 cents, beating the estimate of -91 cents. With 845.16K shares outstanding, the current market capitalization sits at 726.46M.

View a ticker or compare two or three

Compare

PHAT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PHAT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PHAT showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

100 Campus Drive

Phone

+1 877 742-8466

Employees

452

Web

https://www.phathompharma.com